Products for Research Use Only

Rimantadine

CAT: 0804-HY-B0338-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0338-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rimantadine (1-Rimantadine) is an orally active inhibitor for M2 protein, which blocks the hydrogen ion channel activity, prevents the entry and replication of the virus, and exhibits board-spectrum antiviral activity. Rimantadine significantly inhibits hepatitis A virus (HAV) replication at the post-entry stage in Huh7 cells. Rimantadine enhances autophagy. Rimantadine has a significant protective effect against H3N2 virus in mouse model[1][2].
CAS Number
13392-28-4
Product Name Alternative
1-Rimantadine
UNSPSC
12352211
Hazard Statement
H315, H319, H320
Target
Autophagy; Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection; Autophagy
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/rimantadine.html
Purity
99.86
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC(C1(C[C@H](C2)C3)C[C@H]3C[C@H]2C1)N
Molecular Formula
C12H21N
Molecular Weight
179.30
Precautions
H315, H319, H320
References & Citations
[1]Sasaki-Tanaka R, et al., Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy. J Virol. 2022 Sep 28;96 (18) :e0064622.|[2]Simeonova L, et al., Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice. Antiviral Res. 2012 Aug;95 (2) :172-81.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Launched